<DOC>
	<DOCNO>NCT00400257</DOCNO>
	<brief_summary>The investigator hop identify early heart failure patient symptoms yet time assess usefulness Brain natriuretic peptide ( BNP ) .</brief_summary>
	<brief_title>Screening Evaluation Evolution New Heart Failure ( SCREEN-HF )</brief_title>
	<detailed_description>Measuring Brain natriuretic peptide ( BNP ) N-terminal proBNP ( NT-proBNP ) give u useful information person heart function patient symptoms shortness breath . This BNP/NT-proBNP level rise heart pressure people heart disease . However , n't know useful test people high risk develop heart disease symptom diagnose heart problem . In study hope recruit 3500 participant . This study run conjunction HBA ( recently rename Bupa ) estimate 10,000 HBA member need contacted letter invite screen study achieve require 3500 ( protocol amend include people meet entry criterion insured HBA ) . This protocol amend allow u invite 50 participant low NT-proBNP level also continue study blood test , ECG echocardiography describe . Participants undergo routine blood test include measure NT-proBNP . Only participant NT-proBNP elevate undergo additional blood test ( cardiac marker ) , ECG echocardiography determine indication heart disease even though diagnose symptomatic .</detailed_description>
	<mesh_term>Heart Failure</mesh_term>
	<criteria>1 . Age â‰¥60 year 2 . Have insure HBA 12 month longer ( Protocol amend remove criterion allow enrollment general public ) 3 . Subjects highrisk subsequent development heart failure ; comprise least one : Prior myocardial infarction ( MI ) without know left ventricular ( LV ) dysfunction Current active ischemic heart disease Prior Cerebrovascular Accident ( CVA ) Known valvular heart disease without know LV dysfunction Atrial fibrillation Ventricular arrhythmia result syncope presyncope ( protocol amend remove entry criterion ) Treated hypertension , least 2 year duration Treated Diabetes mellitus , least 2 year duration Estimated Glomerular Filtration Rate ( eGFR ) &lt; 50ml/min 1 . Known systolic diastolic heart failure 2 . Symptoms suggestive current heart failure . ( protocol amend remove criterion ) 3 . LV systolic diastolic dysfunction echocardiography objective imaging modality . 4 . Medications treatment heart failure ACE inhibitor , angiotensin receptor blocker ( ARBs ) , betablockers aldosterone antagonist . Use medication approve indication hypertension , postMI management ( without know LV dysfunction ) diabetic nephropathy permit . ( protocol amend remove criterion )</criteria>
	<gender>All</gender>
	<minimum_age>60 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2016</verification_date>
	<keyword>Heart Failure</keyword>
	<keyword>BNP</keyword>
</DOC>